Our study showed that inhibition of cancer proliferation and tumor growth by anti-CEACAM6 antibodies inhibits levels of Tyr397 FAK phosphorylation to suppress FAK-activated signaling pathways [63]. This evidence concerns the gene PTK2 and neoplasm.